Piotr Serwatowski

Author PubWeight™ 29.25^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.	J Clin Oncol	2008	17.30
2	Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.	J Clin Oncol	2007	4.94
3	Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.	J Clin Oncol	2012	4.44
4	Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.	J Clin Oncol	2009	1.30
5	Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.	Carcinogenesis	2008	1.04
6	Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer.	Breast Cancer Res Treat	2006	0.89
7	Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population.	PLoS One	2011	0.88
8	Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer.	Anticancer Drugs	2015	0.75